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In cystic fibrosis, the most common disease-causing mutation is F508del, which causes 
not only intracellular retention and degradation of CFTR, but also defective channel gating 
and decreased membrane stability of the small amount that reaches the plasma membrane 
(PM). Thus, pharmacological correction of mutant CFTR requires targeting of multiple 
cellular defects in order to achieve clinical benefit. Although small-molecule compounds 
have been identified and commercialized that can correct its folding or gating, an efficient 
retention of F508del CFTR at the PM has not yet been explored pharmacologically 
despite being recognized as a crucial factor for improving functional rescue of chloride 
transport. In ongoing efforts to determine the CFTR interactome at the PM, we used 
three complementary approaches: targeting proteins binding to tyrosine-phosphorylated 
CFTR, protein complexes involved in cAMP-mediated CFTR stabilization at the PM, and 
proteins selectively interacting at the PM with rescued F508del-CFTR but not wt-CFTR. 
Using co-immunoprecipitation or peptide–pull down strategies, we identified around 400 
candidate proteins through sequencing of complex protein mixtures using the nano-LC 
Triple TOF MS technique. Key candidate proteins were validated for their robust interaction 
with CFTR-containing protein complexes and for their ability to modulate the amount of 
CFTR expressed at the cell surface of bronchial epithelial cells. Here, we describe how we 
explored the abovementioned experimental datasets to build a protein interaction network 
with the aim of identifying novel pharmacological targets to rescue CFTR function in cystic 
fibrosis (CF) patients. We identified and validated novel candidate proteins that were 
essential components of the network but not detected in previous proteomic analyses.
Keywords: CFTR, interactome, membrane traffic, network biology, plasma membrane
INTRODUCTION
CFTR is a polytopic integral membrane protein that belongs to the ATP-binding cassette (ABC) 
transporter superfamily functioning as cAMP- and phosphorylation-regulated chloride and 
bicarbonate at the apical membrane of epithelial cells. Mutations in the CFTR gene cause cystic 
fibrosis, the most common autosomic recessive disorder among Caucasians (Riordan, 2008). The 
most prevalent CF-causing mutation is F508del, which is present in about 90% of CF patients and 
generates a mutant protein recognized by endoplasmic reticulum (ER) quality control (ERQC) 
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mechanisms (Farinha and Amaral, 2005; Farinha et al., 2013; 
Farinha and Canato, 2017) and targeted for proteasomal 
degradation (Jensen et al., 1995).
Although most F508del-CFTR protein is only detected 
as a non-native (misfolded) core-glycosylated ER-specific 
intermediate, a small amount reaches the plasma membrane 
(PM) and is partially functional as a channel (Dalemans et al., 
1991; Swiatecka-Urban et al., 2005). Thus, one important focus 
of basic research in CF involves attempts to rescue F508del-
CFTR to the PM, by identifying either the key molecular factors 
involved in its ER retention or small molecules that promote 
its folding and release from the ERQC. Recent advances in the 
field allowed the identification of small molecules with potential 
to treat the basic defect in CF—either correctors, promoting 
the relocation of F508del-CFTR from the ER to the PM or 
potentiators, promoting channel activity (for variants already 
located at the PM). Among these, the potentiator VX-770 alone 
or its combinations with the correctors VX-809 or VX-661 
made their way to the clinical practice, securing approval from 
the EMA and the FDA. However, results of these modulators in 
patients bearing F508del suggest that a physiologically relevant 
restoration of function will require additional small molecules 
with distinct corrective properties (Farinha and Matos, 2016). 
This may be due to the fact that F508del-CFTR, despite its partial 
pharmacological rescue of intracellular retention and impaired 
channel regulation, still presents decreased stability at the PM 
(Sharma et al., 2004; Swiatecka-Urban et al., 2005). Whereas 
the retention and the gating defects have been extensively 
studied, and both small-molecule correctors and potentiators are 
available, CFTR membrane stability is a less understood aspect, 
albeit crucial to restore F508del-CFTR to levels that correspond 
to clinical benefit.
CFTR traffic and activity at the PM is the result of numerous 
interactions that function as molecular switches (Amaral, 2005; 
Farinha et al., 2013) modulating channel activity and controlling 
the number of channel present at the membrane, through 
regulation of the secretory and membrane recycling pathways. 
This complex network of proteins is the last step in the control of 
the overall biogenesis/function of the protein and includes other 
transporters, channels, and trafficking machinery components 
(Rab GTPases, SNAREs, PDZ-domain-containing proteins) as 
well as different types of molecular switches (such as kinases, 
phosphatases, and small GTPases) (Guggino and Stanton, 2006; 
Farinha et al., 2013; Farinha and Canato, 2017).
Several mechanisms have been described to regulate CFTR 
anchoring and trafficking at the PM, which include CFTR 
phosphorylation by different kinases, interaction with cAMP 
sensors, or response to small GTPase signaling.
Phosphorylation in the regulatory region of CFTR is known for 
long to be required for its activity and it involves protein kinases 
A (PKA) and C (PKC) (Schultz et al., 1999). Together with PDZ-
domain containing proteins, phosphorylation is responsible for 
the formation of multiprotein signaling complexes that provide 
spatial and temporal specificity to CFTR function (Guggino and 
Stanton, 2006). Besides this well-documented role on function, 
phosphorylation by spleen tyrosine kinase (Syk) in NBD1 (Luz 
et al., 2011; Mendes et al., 2011) or by lemur tyrosine kinase 2 
LMTK2 in the R region (Luz et al., 2014) was shown to control 
the levels of CFTR at the PM.
cAMP levels in the cell lead to PKA activation and hence 
promote CFTR function, as described above. cAMP also activates 
members of guanine nucleotide-exchange factors, called EPACs 
(exchange proteins directly activated by cAMP), whose activation 
does not lead to PKA activation (Bos, 2006). Activation of EPAC1, 
the most abundant EPAC family member expressed in the lung, 
promotes its interaction with CFTR, leading to its stabilization 
at the PM through interaction with the PDZ-containing anchor 
protein NHERF-1 (Lobo et al., 2016).
Overexpression of NHERF1 promotes apical expression of 
the F508del-CFTR mutant channel (Guerra et al., 2005). This 
effect relies on the activation of endogenous RAC1 signaling and 
may also contribute to the increase of F508del-CFTR PM levels 
(Moniz et al., 2013; Loureiro et al., 2015).
Here, we used network biology to identify relevant protein 
nodes that may connect the interactomes obtained by analyzing 
different mechanisms regulating CFTR stability, namely, through 
phosphorylation by SYK or activation of EPAC1 or RAC1. We 
focused the network analysis on proteins never described to 
interact with or regulate CFTR and show that this approach is 
a valid strategy for finding novel regulators of CFTR function 
and traffic. Network biology thus proves to be a tool capable of 
contributing insights into the etiology of other human diseases 
linked to chloride transport or membrane protein traffic.
MATERIALS AND METHODS
Protein Interaction Networks
Human physical protein–protein interaction data were extracted 
from HuRI (Human Reference Protein Interactome Mapping 
Project) (interactome.baderlab.org) (Rual et al., 2005; Venkatesan 
et al., 2009; Yu et al., 2011; Rolland et al., 2014; Yang et al., 2016) and 
APID (Agile Protein Interaction DataAnalyzer) (apid.dep.usal.es) 
(Alonso-Lopez et al., 2016) databases (accessed in June 2018). 
APID gathers literature-reported protein interactions, while HuRI 
results from unbiased large-scale screens for binary interactions. 
We constructed undirected and unweighted networks using Igraph 
R-package (Csardi and Nepusz, 2006). Loop and multiple edges 
were eliminated and only the main component of the network 
was selected. The network was further filtered to contain only 
proteins that are not exclusively located in nucleus, mitochondria, 
or peroxisomes. Gene ontology cellular component annotations 
obtained from UNIPROT were used to define protein subcellular 
location. This filter was necessary since the relevant interactions 
affecting CFTR stability at the PM should not occur within these 
three cellular compartments. The resulting operational network 
contained 17,218 proteins and 252,472 interactions.
Network Analysis
Candidate proteins were selected through a neighbor enrichment 
test and a bridge score. The neighbor enrichment test evaluates 
if the set of direct neighbors of a candidate protein is enriched 
in members of an input protein set using a hypergeometric test. 
The bridging score quantifies for every node in a network its 
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relevance in connecting two other nodes (provided as inputs) 
through short paths of length 2, 3, or 4. It counts the fraction of 
paths of length 2, 3, or 4 linking the two input nodes that contain 
a candidate node. These fractions for each length are used in 
a weighted sum where paths of length 2 have weight 1, paths 
of length 3 have weight 0.5, and paths of length 4 have weight 
0.25. Both methods are implemented as R functions (specific_
neighbors and bridge_score, respectively) publicly available in the 
NetSetStat repository (github.com/GamaPintoLab/NetSetStat). 
Proteins selected through both methods were analyzed for 
biological process enrichment using the DAVID tool (Huang 
Da et al., 2009a; Huang Da et al., 2009b) with the Homo sapiens 
genome as background and testing terms from the FAT subset of 
the Biological Process branch of Gene Ontology. Enriched GO 
terms were considered significant with a False Discovery Rate 
lower than 0.05 and were excluded if their background frequency 
was greater than 10% or lower than 5%.
Preparation of siRNA-Coated 96-Well 
Plates
Two siRNAs against each of the following targets (CUL3, 
GABARAP, GABARAPL1, GABARAPL2, ILK, IQGAP1, 
LRRK2, NF2, NOS2, SMURF1, and UBASH3B) were acquired 
as a cherry-pick siGenome library (Dharmacon, Cambridge, 
UK); 96-well plates were coated with customized siRNAs for 
solid-phase reverse transfection. For that, a transfection mixture 
of 300 µl was prepared containing 161.5 µl of the Lipofectamine 
2000 (Invitrogen #11668019) and 138.5 µl of 0.4 M sucrose in 
OptiMEM solution. Then, 1.25 µl of siRNA 20 µM was added per 
well into 96-conic well plates (siRNA plate); 1.75 µl of transfection 
mix was added per well to siRNA plate, followed by mixing and 
centrifugation for 1 min at 50×g. After 30 min incubation at room 
temperature, 1.75 µl of 0.2% (w/v) gelatin solution was added to 
the siRNA plate and centrifuged at 50×g. Then, the total of 4.25 
µl of the mix in siRNA plate (siRNA plus transfection mix plus 
gelatin) was diluted 1:50 in a 96-conic well plate using double-
distilled water. Finally, 50 µl from the diluted mix was lyophilized 
and stored in an anhydrous atmosphere before cell seeding.
Reverse Transfection With siRNA
CFBE cells expressing an inducible doxycycline promotor for 
mCherry-Flag-CFTR (kind gift of Prof. Margarida Amaral, 
Lisbon) were grown to confluence and split. Then, after 24  h, 
cells were seeded in a siRNA-coated 96-well plate (100 µl of cell 
suspension/well, 7 × 10 7 cells/well) using a Multidrop™ Combi 
Reagent Dispenser (Thermo Scientific #5840300). After 24 h of 
reverse transfection, CFTR expression was induced for 24 h for 
wt-CFTR and 48 h for F508del-CFTR, using 1 µg/ml doxycycline 
(Sigma #9891) in antibiotic-free medium.
CFTR Trafficking Assay
The CFTR trafficking assay was performed as previously 
documented (Almaca et al., 2011; Botelho et al., 2015). This 
assay uses a double-tagged version of CFTR with mCherry 
at the N-terminus and FLAG at the fourth extracellular loop. 
Usage of the mCherry tag allows for quantification of the total 
amount of CFTR protein expressed by each individual cell. 
The Flag tag allows one to quantify CFTR that is exclusively 
localized at the cell surface by usage of an antibody applied 
extracellularly without cell permeabilization. Hence, 72 h after 
seeding and siRNA knockdown, cells were washed once with 
cold PBS+/+ (1× PBS supplemented with 0.9 mM CaCl2, 0.5 mM 
MgCl2, pH 7.2) using Tecan Hydrospeed™ and immunostained 
for the extracellular Flag-tag (in non-permeabilized cells) for 
1  h at 4°C with 1:500 anti-Flag® M2 monoclonal antibody 
(Sigma-Aldrich #F1804). Then, cells were washed three times 
in ice with cold PBS+/+ and incubated 20  min with 3% (w/v) 
paraformaldehyde (PFA) at 4°C. Cells were then washed three 
times in ice with cold PBS+/+ and incubated with anti-mouse 
Cy5 conjugated secondary antibody (Invitrogen, #A10524). 
Cells were washed three times in ice with cold PBS+/+ and 
incubated for 1 h with 1:5000 Hoechst 33342 solution (Sigma 
#B2261) for nucleus staining. Finally, cells were washed in ice 
with cold PBS+/+ and immersed in PBS+/+. All solutions were 
prepared in PBS+/+ and primary and secondary antibodies were 
diluted in PBS+/+ supplemented with 1% (v/v) BSA.
Image Acquisition
Cell imaging was performed at room temperature with an 
inverted wide-field fluorescence microscope Leica DMI6000 
equipped with a 12-bit 1,344 × 1,024 pixel resolution DFC360FX 
camera (Leica) and a 10× objective. Exposure times at maximum 
light brightness for Hoechst, mCherry, and Cy5 were 50, 1,300, 
and 8,000 ms, respectively. The Hoechst channel was used for 
contrast-based autofocus. The experiment was conducted in 
triplicate and five images per well were collected.
Image Analysis
Automatic image analysis was performed using open-source 
software tools [cell image analysis software CellProfiler1 
(Carpenter et al., 2006) and R2] and a pipeline to measure CFTR 
traffic efficiency developed previously (Botelho et al., 2015). 
Using this pipeline, the background subtraction was first applied 
to each image to correct the image illumination and background 
fluorescence. Then, a quality control was also applied for each 
image to exclude cells that do not significantly express CFTR, 
present abnormal morphology, or contain a significant number 
of saturated pixels. Finally, CFTR traffic was measured in each 
cell using the fluorescence quantification according to the 
following formula:
 
CFTR Traffic Efficiency PM CFTR
Total CFTR
Cy5 Integr
=
= ated Fluorescence
IntegratedmCherry Fluorescence
(Formula1)
CFTR traffic efficiency was calculated using the median CFTR 
traffic efficiency for all cells in the image. Using this pipeline, we 
1 CellProfiler, http://cellprofiler.org/ (last accessed October 19, 2017).
2 R program, https://www.r-project.org/ (last accessed March 09, 2018).
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also remove out-of-focus images, images with high background 
fluorescence, and images with a lower number of cells (less 
than 20 cells). Then, the average of CFTR traffic efficiency for 
all images in wells transfected with siRNAs, which passed the 
quality control (traffic efficiency test), was compared with the 
one measured under control conditions—siRNA EGFP (Traffic 
Efficiencycontrol) according to the following formula:
 DeviationScore Traffic Efficiency Traffic Efftest= − iciencySEM
control
control2 ×
( )Formula 2
The standard error of the mean for the Traffic Efficiency is 
given by the SEMcontrol recorded for siRNA EGFP. Deviation scores 
(DSs) that are positive or negative correspond to traffic enhancers 
or inhibitors, respectively. The DS equation normalizes the Traffic 
Efficiency measures to the mean and variation of the negative 
controls included in the same 96-well plate. This normalization 
facilitates the comparison between independent replicates, as all 
values are relative to the mean and standard error of the mean 
(SEM) of the negative controls in the respective plate. A DS of 1 
is the double of the negative control SEM, which means that the 
latter has a normalized value of 0.5.
Analysis of siRNA Knock-Down Efficiency
CFBE cells constitutively expressing F508del-CFTR were seeded in 
96-well dishes and transfected with the panel of siRNAs described 
above (Dharmacon, Cambridge, UK), using Lipofectamine 
2000 (Invitrogen). All cells were incubated for 48 h at 37°C with 
5% CO2 and then RNA was extracted with the NucleoSpin RNA 
kit (Macherey Nagel, Düren, Germany). For cDNA synthesis, 
0.5 μg of total RNA was then reverse transcribed using random 
primers (Invitrogen/Life Technologies) and Ready-to-Go You-
Prime beads (GE Healthcare, Buckinghamshire, UK). Real-
time PCR quantification (qPCR) was performed as previously 
described (Matos et al., 2008). Primers used in qPCR for each 
of the targeted transcripts are described in Table 1. Each cDNA 
sample was diluted fivefold to guarantee accurate pipetting 
and 5 μl was added to each real-time reaction together with 
250 nM primers and SYBR Green Master Mix (Applied Biosystems/
Life Technologies). Data were analyzed with the ABI Prism 7000 
SDS 1.1 RQ Software (ΔΔCT method, Applied Biosystems/Life 
Technologies).
CFTR Functional Assay by Halide-Sensitive 
YFP (HS-YFP)
CFBE cells constitutively expressing wt- or F508del-CFTR 
together with HS-YFP-F46L/H148Q/I152L (Galietta et al., 
2001) were seeded in eight-well chamber slides. F508del-CFTR 
cells were seeded in duplicate slides. Cells were then transfected 
with either siLUC (Eurofins MWG Operon), siGABARAP_1, 
siSMURF1_2, or siENOS_2 (Dharmacon) using Lipofectamine 
2000 (Invitrogen). All cells were incubated for 48 h and VX-809 
(3 μM; Gentaur) was added to one of the F508del-CFTR cell sets. 
Cells were carefully washed twice with isomolar PBS (WPBS: 137 
mM NaCl, 2.7 mM KCl, 0.7 mM CaCl2, 1.1 mM MgCl2, 1.5 mM 
KH2PO4, 8.1 mM Na2HPO4, pH 7.4), and wt-CFTR cells were 
incubated for 15 min in WPBS containing 1 μM indomethacin 
to reduce endogenous cAMP levels. Cells were then transferred 
to a Leica TCS-SPE confocal microscope for time-lapse analysis. 
Each well was assayed individually for iodide influx by recording 
fluorescence continuously (500 ms per point), first for 10 s 
(baseline) and then for 60 s after the rapid (≤1 s) addition of 
isomolar PBS, containing either 5 μM Forskolin (Fsk) (wt-CFTR 
cells) or 5 μM Fsk plus 20 μM Gen (F508del-CFTR cells), in which 
137 mM Cl− was replaced by I− (IPBS; final NaI concentration 
of 100 mM/plate well). Cells were kept at 37°C up until being 
assayed at room temperature. After background subtraction, 
HS-YFP fluorescence recordings (F) were normalized to 
the initial average value measured before addition of I− (F0). 
Quantification of fluorescence decay was performed on at least 
24 individual cells per well, using ImageJ (NIH) as previously 
described (Matos et al., 2018). The average fluorescence decay 
was fitted to an exponential decay function to derive the maximal 
slope [d(F/F0)/dt, at t = 0] that is proportional to the initial influx 
of I− into the cells. (Loureiro et al., 2015).
Protein Thermal Destabilization Assay 
(Thermal Shift Assay, TS)
After Dox-induced CFTR expression (1 μg/ml; Sigma-
Aldrich), mCherry-Flag-F508del-CFTR CFBE cells were 
transfected with either siLUC (Eurofins MWG Operon) or 
siGABARAP_1 (Dharmacon), using Lipofectamine 2000. 
Cells were then incubated for 24  h with VX-809 (3 μM; 
Gentaur) at 37°C and then moved for another 24 h to 30°C, 
to increase the thermal stability of rescued F508del-CFTR 
TABLE 1 | Primers used for qPCR quantification of siRNA efficiency.
Gene name Transcript_id Forward primer sequence Reverse primer sequence
CUL3 NM_003590.4 ACAGCTATGGTGATGATTAGAGAC TACGACTTCTCCTTTCCGCT
GABARAP NM_007278.1 GGCTCCCAAAGCTCGGATAG GCAGCTTCACAGACCGTAGA
GABARAPL1 NM_001363598 TGCCTGATCTGGACAAGAGG AACGCATCTAGAACAAGGGCT
GABARAPL2 NM_007285.6 TGTTCAAGGAGGACCACTCG CCACAAACAGGAAGATCGCC
ILK NM_004517.3 GCTTGGGGTTCATCCTCCTT TTACATTGATCCGTGCCCCC
IQGAP1 NM_003870.3 GCACTGGCTAAGACGGAAGT CGGATAGCACGTCTCTGCAT
LRRK2 XM_005268629.4 GGCCCTCCTCACTGAGACTA TGCATCAGCATGGAGAGCAT
NF2 NM_181832.2 AGAGGAGCTGGTTCAGGAGA GCCAAAAATCCCCGCTTGTG
NOS2 NM_000625.4 CCTCGCTCTGGAAAGACCAG GGGACAGGACGTAGTTCAGC
SMURF1 NM_181349.2 CGTGGGGAAGAAGGTTTGGA AAGCCCCCGTTGATGTAGTG
UBASH3B NM_032873.4 TGGACGTGCTCCTCTCCAT GGGGAAGATGTTGTGTGCCT
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at the PM and allow its accumulation at the cell surface. For 
the thermal shift assay, cells were again transferred to 37°C 
for 4 h to induce F508del-CFTR thermal destabilization and 
PM removal, as described previously (Okiyoneda et al., 2010). 
Cells were then placed on ice, washed three times with ice-
cold WPBS, and left 5 min in cold WPBS to fully arrest CFTR 
trafficking. Afterwards, they were incubated on ice with anti-
Flag M2 Ab (F3165, Sigma-Aldrich) in WPBS for 1 h at 4°C, 
without permeabilization. Cells were washed three times with 
ice-cold WPBS and incubated with anti-mouse Alexa Fluor 
488 secondary Ab (Thermo Fisher Scientific) for 1 h at 4°C. 
Cells were then fixed with 4% formaldehyde for 15  min, 
thoroughly washed in PBS containing DAPI (4´,6-diamidino-
2-phenylindole, Sigma-Aldrich), mounted on microscope 
slides with Vectashield (Vector Laboratories), and analyzed by 
confocal microscopy.
Confocal Microscopy Imaging
Slides of mCherry-Flag-F508del-CFTR CFBE cells immunolabeled 
with anti-Flag followed by Alexa Fluor 488 were analyzed by 
confocal microscopy. Images were acquired on a Leica TCS-
SPE confocal microscope, where mCherry fluorescence is 
proportional to the total amount of CFTR, Alexa Fluor 488 
fluorescence is proportional to the amount of CFTR present 
at the cell surface, and nuclei were stained with DAPI. A 0.2-
μm Z-stack of 1-Airy confocal images was acquired to select 
the best XY plane to analyze the CFTR protein at the cell 
surface. ImageJ software (NIH) was then used to delimitate 
each single cell as individual ROIs (regions of interest, to allow 
measurement of mCherry and Alexa488 fluorescence signal 
intensities). Quantification of fluorescence was performed on 
at least 24 individual cells per field, as previously described 
(Matos et al., 2018), and expressed as mean ± SEM fold variation 
over control cells.
Statistical Analysis
Multiple treatment data analysis—Statistical significance of the 
observed variations between different treatments was assessed 
using two-tailed Kruskal–Wallis tests, followed by paired 
comparisons using the Mann–Whitney U test, considering 
a 0.05 significance level for both tests. All observations were 
confirmed in at least three independent experiments, each with 
two replicates for each individual condition tested.
Statistical analysis of CFTR trafficking assay—Each siRNA was 
used to measure traffic efficiency of wild-type CFTR, F508del-
CFTR, and F508del-CFTR rescued with VX-809. For each siRNA 
and CFTR type, three independent replicate DSs were obtained. 
The DS mean was considered a measure of the siRNA capacity to 
influence the traffic efficiency of a particular CFTR type (<DSi>, i 
corresponding to CFTR type), and the sum of the three DS mean 
absolute values (Σ|<DSi>|) was considered a global measure of the 
siRNA effect. To evaluate statistical significance of these effects, a 
random permutation test was performed, where the data matrix 
containing all the individual DS (all replicates for all CFTR 
types and all siRNAs, including siRNAs without knockdown 
effect, functioning as additional controls) was randomly shuffled 
10,000 times. Full matrix permutation is possible because all DS 
values are normalized by EGFP control traffic efficiency mean 
and SEM values. For each random matrix, each siRNA random 
Σ|<DSi>| was computed, generating distributions according to 
the null hypothesis that siRNAs have no effect. Null hypotheses 
were rejected when the fraction of random values greater than or 
equal to the observed Σ|<DSi>| was lower than 0.05.
RESULTS
Network Connectivity between CFTR 
Interactors Potentially Modulating Stability 
at the PM
Studies from our team have identified five sets of CFTR interactors 
through three parallel approaches (under consideration elsewhere): 
a) proteins selectively interacting at the PM with either wt-CFTR 
(set 1: wt) or rescued F508del-CFTR (set 2: rescued), b) protein 
complexes involved in cAMP-mediated CFTR stabilization (set 3: 
EPAC), and c) adaptor proteins binding to tyrosine-phosphorylated 
(set 4: pep-py) or un-phosphorylated (set 5: pep-wt) CFTR peptide 
(unpublished data). All these complementary approaches were 
designed to identify potential modulators of CFTR PM stability 
through different pathways. We hypothesized that proteins 
simultaneously interacting with these different pathways may also 
have a significant influence on CFTR stability at the PM.
First, we mapped these sets of interactors on a human protein 
physical interaction network and explored how strongly they 
were connected through this network (Table 2). To evaluate the 
statistical significance of network connectivity, we had to consider 
that these interactor sets were selected by their presence in 
immunoprecipitated CFTR complexes. Therefore, we generated 
500 random sets of interactors (for each of the five observed 
sets), with the same number of proteins at each observed network 
distance from CFTR. For each connectivity property (number of 
overlapping proteins between sets, number of direct interactions 
between set members, and number of common direct neighbors 
between sets), we recorded the average value across the 500 
randomizations and a p value, which corresponds to the fraction of 
random set pairs showing a value higher than that observed with 
the experimental sets. The five sets have a low number of proteins 
in common, although 8 out of 10 pairs have a significantly higher 
overlap than expected by chance. The strong connectivity between 
these CFTR interactor sets is much more evident by looking at the 
numbers of direct physical interactions and common neighbors 
that are much higher than randomly expected and reach statistical 
significance for all set pairs. This strong connectivity supports 
our attempt to find new proteins simultaneously interacting with 
multiple CFTR PM stability-related pathways.
Specific Common Neighbors of CFTR 
Interactor Sets
We have identified 4411 proteins that have direct physical 
interactions with proteins in at least two CFTR interactor sets 
(2,420, 1,161, and 443 with direct neighbors in at least 3, 4, and 
5 sets, respectively). However, to increase the likelihood that 
perturbations in one of these proteins will have an effect in these 
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specific neighbor pathways and, consequently, on CFTR PM 
stability, we should require that these proteins are enriched in 
direct interactions with these CFTR interactor sets. With that 
aim, we performed a hypergeometric test to determine if these 
proteins are enriched in interactions with each of the five sets. 
As we performed this test to all proteins with neighbors in each 
of the five interactor sets, choosing a trivial p value cutoff may 
be associated with many false positives. To avoid this multiple 
testing problem, we selected for each set of CFTR interactors the 
5% proteins with the lowest hypergeometric p values as specific 
neighbors of that set, and additionally required the selected 
proteins to have at least three interactions with two or more 
CFTR interactor sets. This strategy resulted in the selection of 
478 proteins. We ranked these proteins by summing the ranks 
of their neighbor enrichment p values for all sets, discarding sets 
where the protein was not in the top 5% of significantly enriched 
proteins (protein list and associated statistics are available in 
Supplementary Table 1 and the selection process is depicted in 
Figure 1).
Important Mediators of CFTR Interaction 
With EPAC, NHERF1, EZRIN, and SYK
The CFTR interactor sets were experimentally detected under 
conditions that modulate CFTR PM stability through the influence 
of factors such as EPAC, NHERF1, EZRIN, and SYK, previously 
known to be involved in the stabilization process (Mendes et al., 
2011; Loureiro et al., 2015; Lobo et al., 2016). To uncover novel 
proteins that most likely influence CFTR PM stability, we aimed 
to quantify the contribution of a given protein to interfere (either 
positively or negatively) with the formation of complexes including 
CFTR and one of the referred stability factors.
For this purpose, we developed a bridge score that measures 
the fraction of short length paths (with two to four interactions) 
connecting two proteins of interest (CFTR and the stability 
factor) that are mediated by a candidate protein. Mediation of 
shorter paths is given a higher weight/score. The perturbation 
of proteins with high bridge scores will disrupt a higher 
fraction of short network paths linking the two proteins of 
interest. If the interactions in these paths stabilize or facilitate 
the assembly of the complex containing the two proteins of 
interest, the bridging protein may have a positive effect on the 
functional interaction between the two proteins. Reversely, if 
the interactions in the short paths compete with the formation 
of the complex, the bridging protein may negatively affect the 
functional interaction between the two proteins.
To compute the bridge score, we assembled a connected 
subnetwork containing CFTR, the four stability factors, and the 
common neighbors identified in the previous section (process 
described in Figure 1). The resulting subnetwork contained 
482 proteins and 16,481 interactions. We considered a protein 
to be an important mediator between CFTR and one stability 
factor if its bridge score was in the top 25% of all scores with 
the corresponding stability factor. This procedure allowed the 
identification of 194 strong mediator proteins (Supplementary 
Table 1). Gene ontology analysis (Supplementary Table 2) 
showed that the two biological processes most significantly 
enriched within these 194 proteins were “protein localization to 
organelle” (GO:0033365, 54 proteins) and “regulation of protein 
modification process” (GO:0031399, 71 proteins), which supports 
their hypothetical role in the modulation of CFTR PM stability.
Hit Selection
To assess the impact of protein networks in CFTR trafficking, we 
selected hits for validation from the list of 478 proteins significantly 
enriched in neighbors from at least two CFTR interactor sets.
From the list of specific common neighbors of CFTR interactors, 
we started by excluding any proteins detected in the three initial 
experimentally derived interactor sets. Then, we focused on the 
top 25% of the list (proteins with higher neighbor enrichment rank 
sum as defined above). Then, we used data from Human Protein 
Atlas and excluded proteins with low expression in the “bronchus” 
(keeping thus only those with medium, high, or n/a protein 
expression). As we were interested in assessing CFTR PM stability, 
we then excluded proteins with annotation as ribosomal proteins/
elongation or transcription factors/HNRNP/RNA processing/
nuclear proteins. The next step was to exclude proteins already 
detected as CFTR interactors in previous studies (Wang et al., 2006; 
Pankow et al., 2015). This refined our list from 478 to 44 proteins. 
Finally, we used literature mining and refined this list to 25%, 
selecting 11 possible hits for validating the proteins listed in Table 3.
TABLE 2 | Overlap, direct interactions, and common neighbors between CFTR interactor sets.
CFTR interactor sets Overlap Direct interactions Common neighbors
Observed 
(expected)
p Observed 
(expected)
p Observed 
(expected)
p
wt rescued 7 (1.2) <0.002 183 (48.1) <0.002 2,092 (1,244) <0.002
EPAC 3 (0.4) 0.004 54 (16.9) <0.002 1,138 (692) 0.006
pep-py 2 (0.3) 0.024 82 (15.3) <0.002 1,535 (661) <0.002
pep-wt 0 (0.2) 0.547 28 (5.6) <0.002 888 (310) 0.002
Rescued EPAC 8 (1.1) <0.002 164 (44.8) <0.002 1,818 (1,191) 0.006
pep-py 6 (0.9) 0.002 359 (41.8) <0.002 2,300 (1,153) <0.002
pep-wt 3 (0.3) 0.002 113 (15.3) <0.002 1,364 (515) <0.002
EPAC pep-py 1 (0.2) 0.117 57 (14.0) <0.002 1,140 (636) 0.002
pep-wt 2 (0.1) 0.002 23 (5.2) <0.002 758 (301) 0.008
pep-py pep-wt 4 (0.1) <0.002 94 (5.0) <0.002 1,473 (294) <0.002
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Assessment of CFTR Trafficking Under 
Knockdown of Selected Hits
We ordered two different siRNAs for each of the putative hit 
proteins from Dharmacon’s siGenome library (see Materials and 
methods). We then used qPCR to assess the knockdown efficiency 
of the targeted transcript by each siRNA in CFBE cells (Figure 
S1). We verified that most siRNA pairs exhibited considerable 
differences in their ability to knock down the abundance of 
the mRNAs coding for the targeted proteins. Notwithstanding, 
we observed that the siRNAs GABARAP_1, GABARAPL2_1, 
IQGAP1_1, LRRK2_2, NF2_2, NOS2_2, and SMURF1_2 were 
able to significantly (p < 0.05) downregulate the hit mRNAs that 
they targeted (Figure S1), and these were chosen for further 
analysis on CFTR trafficking (wt-, F508del-, and F508del-CFTR 
rescued with VX-809). We used CFBE cell lines stably expressing 
a double-tagged (mCherry and FLAG) version of CFTR under 
the control of a doxycycline-inducible promoter so that CFTR 
expression could be induced 24 h after transfection with siRNA 
and immunofluorescence be performed at 24 h post-induction. 
CFTR at the PM is monitored by the Flag (Cy5) signal and total 
CFTR by mCherry fluorescence. CFTR trafficking is given by the 
ratio of PM CFTR to total CFTR (Botelho et al., 2015).
For this assay, cells were also transfected with two previously 
validated siRNAs targeting CFTR and COPBI (Botelho et al. 2015), 
as controls of the transfection efficiency and trafficking 
inhibition, respectively.
Results showed that the different proteins affected differently 
the three CFTR conditions tested (Figure 2). Table 4 summarizes 
the top seven siRNAs that, when transfected into the three 
cell lines, promoted the largest increases in CFTR trafficking 
efficiency.
Altogether, we observed that siRNAs GABARAP_1, 
NOS2_2, and SMURF1_2 elicited consistent increments in the 
trafficking and overall PM levels of VX-809-rescued F508del-, 
wt-, and untreated F508del-CFTR, respectively (Figure 2), 
prompting us to analyze their impact on overall CFTR function 
in CFBE cells.
Knockdown of GABARAP and NOS2 
Modulates wt- and VX-809 Rescued 
F508del-CFTR Function in Opposite Ways
To test the effect of knocking down the expression of the three 
selected candidates on CFTR function, we used a widely used 
and previously validated functional assay, based on the ability 
of iodide to quench the fluorescence of the halide-sensitive 
YFP-F46L/H148Q/I152L mutant (HS-YFP) (Loureiro et al., 
2015; Matos et al., 2018). As shown in Figure 3, knockdown 
of either SMURF1, NOS2, or GABARAP had no apparent 
FIGURE 1 | Diagram of the network analysis procedures. CFTR interactor sets were mapped on a human protein physical interaction network, filtered for protein 
subcellular location to guarantee plausible interactions with CFTR. Proteins in the network were submitted to a neighbor enrichment test to select specific common 
neighbors of the CFTR interactor sets. A subnetwork containing the selected specific neighbors, CFTR, and related stability factors (EPAC, NHERF1, EZRIN, and 
SYK) was assembled and a bridge score was computed to identify strong network mediators of CFTR interaction with the referred stability factors. The ranking of 
neighbor specificity and bridge score were used to select candidates for experimental validation of CFTR PM stability modulation.
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effect on HS-YFP fluorescence in untreated F508del-CFTR 
cells, compared to control cells (siLUC). In contrast, following 
VX-809 treatment of cells to allow some F508del-CFTR protein 
to reach the PM, the downregulation of GABARAP produced a 
moderate but clear effect on HS-YFP quenching (Figure 3A), 
corresponding to a significant (p < 0.05) 1.4-fold increase in the 
initial iodide influx rate, as calculated from the exponential decay 
fit of quantified fluorescence values (Figure 3A). Interestingly, 
whereas the downregulation of either SMURF1 or NOS2 
appeared to have no significant effect on rescued F508del-CFTR, 
the knockdown of NOS2 produced an apparent 40% decrease in 
influx rate, when compared to control (siLUC) cells (Figure 3B). 
Notably, similar and statistically significant opposite effects were 
observed upon the downregulation of GABARAP and NOS2 in 
wt-CFTR cells (Figure 3A and C). Moreover, despite showing no 
observable consequence in the trafficking assay, the increment 
produced by GABARAP knockdown in these cells was clearly 
pronounced, triggering a 2.9-fold faster CFTR response, even 
after endogenous cAMP reduction by pretreatment of the cells 
with 1 μM indomethacin, prior to stimulation with 5 μM Fsk. 
Also noteworthy, the knockdown of SMURF1, which failed to 
produce a clear increase in wt-CFTR PM signal in the trafficking 
assay, produced a significant (p < 0.01) over twofold stimulation 
of the iodide influx rate in these cells (Figure 3C). Overall, 
interference with either of the three candidate proteins interfered 
with functional activity of wt-CFTR, but only GABARAP and 
NOS2 affected the clinically relevant rescued F508delCFTR, 
producing opposite functional outputs.
GABARAP Knockdown Increases the PM 
Stability of VX809-Rescued F508del-CFTR
Because the absolute increment of VX-809-rescued F508del-
CFTR at the cell surface exceeded that computed for its trafficking 
efficiency upon downregulation of GABARAP, we asked whether 
the observed increase in both CFTR PM abundance and ion 
transport would rather reflect an improved stability of the rescued 
channels at the PM. To test this, we used the previously described 
thermal shift assay (Loureiro et al., 2015). This assay employs 
the mCherry-Flag-F508del-CFTR CFBE cell line used for the 
trafficking assay but with a different experimental procedure. 
First, F508del-CFTR is rescued with VX-809 and then stabilized 
at the cell surface by incubating the cells at 30°C for 24 h. Next, 
cells are returned to 37°C for 4 h, which destabilizes the rescued 
mutant channels causing their endocytic removal from the cell 
surface, unless the tested co-treatment procedure is able to delay 
or prevent CFTR internalization. Cells are then stained as before 
and analyzed by confocal microscopy. Images of the cell surface 
are used to quantify the fluorescence signal corresponding to the 
amount of CFTR at the membrane (Figure 4A; see Materials and 
methods). We used treatment with HGF as a positive control, 
since this growth factor was previously shown to induce the 
retention of VX-809-rescued F508del CFTR at the cell surface 
(Moniz et al., 2013; Matos et al., 2018). Indeed, co-treatment 
with HGF not only increased the overall PM abundance of CFTR 
at 30°C, as it was able to promote the surface retention of ~80% of 
the rescued protein, upon switching to 37°C (Figure 4B and C), 
corresponding to ~70% of the wt protein at this temperature 
TABLE 3 | Hits selected for validation.
UniProt identifier Gene Protein Specific neighbor of Strong mediator of CFTR with
Q9H0R8 GABARAPL1 Gamma-aminobutyric acid receptor-associated protein-like 1 
(Early estrogen-regulated protein) (GABA(A) receptor-associated 
protein-like 1) (Glandular epithelial cell protein 1) (GEC-1)
All sets EZRIN, NHERF1, SYK
O95166 GABARAP Gamma-aminobutyric acid receptor-associated protein 
(GABA(A) receptor-associated protein) (MM46)
All sets NHERF1
P60520 GABARAPL2 Gamma-aminobutyric acid receptor-associated protein-like 2 
(Early estrogen-regulated protein) (GABA(A) receptor-associated 
protein-like 2) (Glandular epithelial cell protein 2) 
All sets EPAC, EZRIN, NHERF1, SYK
P35228 NOS2 Nitric oxide synthase, inducible (EC 1.14.13.39) (Hepatocyte 
NOS) (HEP-NOS) (Inducible NO synthase) (Inducible NOS) 
(iNOS) (NOS type II) (Peptidyl-cysteine S-nitrosylase NOS2)
All sets NHERF1
Q5S007 LRRK2 Leucine-rich repeat serine/threonine-protein kinase 2 (EC 
2.7.11.1) (Dardarin)
All sets EPAC, EZRIN, NHERF1, SYK
P35240 NF2 Merlin (Moesin-ezrin-radixin-like protein) (Neurofibromin-2) 
(Schwannomerlin) (Schwannomin)
All sets EZRIN, NHERF1
Q13418 ILK Integrin-linked protein kinase (EC 2.7.11.1) (59 kDa serine/
threonine-protein kinase) (ILK-1) (ILK-2) (p59ILK)
All sets except pep-wt
Q9HCE7 SMURF1 E3 ubiquitin-protein ligase SMURF1 (hSMURF1) (EC 2.3.2.26) 
(HECT-type E3 ubiquitin transferase SMURF1) (SMAD 
ubiquitination regulatory factor 1) (SMAD-specific E3 ubiquitin-
protein ligase 1)
All sets except wt NHERF1, SYK
Q8TF42 UBASH3B Ubiquitin-associated and SH3 domain-containing protein B 
(EC 3.1.3.48) (Cbl-interacting protein p70) (Suppressor of T-cell 
receptor signaling 1) (STS-1) (T-cell ubiquitin ligand 2) (TULA-2) 
(Tyrosine-protein phosphatase STS1/TULA2)
All sets except wt SYK
Q13618 CUL3 Cullin-3 (CUL-3) All sets EZRIN, NHERF1, SYK
P46940 IQGAP1 Ras GTPase-activating-like protein IQGAP1 (p195) All sets except pep-py EZRIN, NHERF1, SYK
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(Figure 4C). Importantly, the knockdown of GABARAP also 
partially prevented the internalization of rescued F508del-CFTR 
(Figure 4B and C). Albeit having a more moderate effect than 
HGF, the absence of GABARAP caused the retention of ~46% of 
the rescued protein at the cell surface at 37°C (~25% of wt-CFTR), 
which when compared to the ~30% control cells (siLUC; ~17% of 
wt-CFTR) reflects a ~1.5-fold increase in surface protein stability, 
in agreement with the observed extent of functional rescue.
DISCUSSION
In this work, we identified novel candidate proteins that are involved 
in the regulation of CFTR membrane traffic and/or its retention at 
the PM. The results were obtained based on experimental data from 
independent proteomic studies conducted in the host lab, namely, 
on PM CFTR levels following phosphorylation by SYK or the 
activation of EPAC1- or RAC1-mediated signaling. Subsequently, 
FIGURE 2 | CFTR trafficking upon knock-down of the possible hits. CFBE cell lines expressing mCherry-Flag-wt-, mCherry-Flag-F508del-, and mCherry-Flag-
F508del-CFTR treated with VX-809 (3 μM for 48 h) under the control of a doxycycline-inducible promoter were transfected with siRNAs targeting CUL3, GABARAP, 
GABARAPL1, GABARAPL2, ILK, IQGAP1, LRRK2, NF2, NOS2, SMURF1, and UBASH3B. NT (non-treated cells) and COPB1 and EGFP (no-target siRNA) siRNA were 
used as controls. (A–C) Representative images for the three cell lines and one target for each cell line. PM CFTR image contrast was optimized after quantification to 
allow visualization of detected signal differences. (D) The CFTR traffic efficiency is obtained with the ratio PM/total CFTR with PM CFTR assessed by Flag staining (Cy5 
fluorescence) and the amount of total CFTR with the mCherry signal. Data are shown as the deviation score as detailed in Formula 2, where positive values correspond 
to traffic efficiencies larger than the negative control (siRNA against EGFP) and negative values correspond to traffic efficiencies lower than the negative control, n = 3.
TABLE 4 | Deviation score (DS)-based analysis of CFTR traffic efficiency for wt- or F508del-CFTR (incubated with either DMSO or VX-809) following the siRNA-
mediated hit protein knockdown.
siRNA <DSwt> <DSF508del> <DSF508del+VX-809> ∑|<DSi>| p
GABARAP_1 −0.433 −0.431 1.049 1.912 0.013
GABARAPL2_1 0.151 −0.570 −0.153 0.875 0.449
IQGAP1_1 0.536 0.264 0.044 0.844 0.479
LRRK2_2 0.031 0.364 −0.146 0.540 0.794
NF2_1 −0.701 0.319 −0.761 1.781 0.023
NOS2_2 0.650 −0.501 −0.549 1.701 0.031
SMURF1_2 0.463 0.533 −0.698 1.693 0.032
DSi (i corresponding to wt-, F508del-, or F508del-CFTR+ VX-809) informs on the siRNA capacity to influence the traffic efficiency of a particular CFTR type. The sum of the three 
DS mean absolute values (∑|<DSi>| ) constitutes a global measure of the siRNA effect. Statistical significance (p) of these effects were calculated using a random 
permutation test (see Materials and Methods for details). Values highlighted in bold when significant.
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the resulting interactomes were explored by computational 
network biology to identify novel protein nodes, never described 
before to interact with or regulate CFTR.
Recently, several authors have proposed network analysis 
methods to find novel proteins in common (or mediating the 
interactions) between two related network modules (Silberberg et 
al., 2017; Garcia-Vaquero et al., 2018). These candidate proteins 
may contribute to the common phenotypes associated with both 
modules. Here, we considered the different sets of CFTR interactors 
as network modules that have in common their potential role in 
regulating CFTR stability at the PM. To seek for novel proteins in 
common between these modules, we selected proteins specifically 
enriched in direct neighbors from at least two of the CFTR interactor 
sets. An analogous strategy has been successfully employed to 
expand the composition of disease-associated network modules 
(Ghiassian et al., 2015). This method requires candidates to have 
known direct interactions with module members, so it is limited by 
the completeness and accuracy of the accessed interaction databases. 
Our analysis is restricted to physical protein interactions, which will 
also limit our ability to find candidates regulating CFTR stability 
through indirect mechanisms such as expression regulation.
Besides the enrichment in protein localization and modification 
processes, the list of candidate proteins identified 12 (AHSA1, BAG3, 
COPS5, HDAC6, HSP90AB1, HSP90B1, HSPA5, LGLALS3BP, 
PABPC1, RACK1, USP19, and YBX1) out of 25 recently reviewed 
putative CFTR-interacting targets for restoring CFTR biogenesis 
and function identified through proteomic approaches (Lim et al., 
2017). Both observations support the validity of our approach.
Among the novel protein nodes identified, the proteins 
encoded by the GABARAP, NOS2, and SMURF1 genes were 
functionally validated in the physiologically relevant bronchio-
epithelial cell line CFBE. For this, the expression of the 
endogenous proteins was depleted by RNA interference and the 
effect on PM localization and function of CFTR was analyzed.
NOS2 encodes the inducible isoform of nitric oxide synthase 
(NOS), which is expressed maximally following an inflammatory 
stimulus and produces relatively large micromolar quantities of NO. 
While macrophages and neutrophils express higher levels of iNOS 
in the lung, it can also be expressed by bronchial epithelial cells. 
NOS2 expression in these cells is upregulated by lipopolysaccharide 
(LPS) and by proinflammatory cytokines, such as interleukin-1, 
tumor necrosis factor alpha, and gamma interferon (Ermert 
et al., 2002). Expression of iNOS appears to be nearly absent in 
bronchial cells from CF patients (Meng et al., 1998; Thomas et al., 
2000; Dotsch et al., 2002) and may be caused by abnormalities in 
the signaling system that normally causes its induction, such as 
cytokine receptors, second messengers, or transcription factors 
(Meng et al., 1998; Satitsri et al., 2016). Given the apparent negative 
FIGURE 3 | Knockdown of selected candidate proteins influences wt- and F508del-CFTR function. (A) Representative fluorescence decay curves of the iodide influx assay. 
Wt- or F508del-CFBE cells stably expressing the HS-YFP sensor were transfected and treated for 48 h, as indicated. Fluorescence microscopy images were acquired 
continuously, first for 10 s (baseline) and then for 60 s after the rapid (≤1 s) addition of isosmotic buffer, containing 100 mM iodide together with either 5 μM Fsk (wt-CFTR cells) 
or 5 μM Fsk plus 20 μM Gen (F508del-CFTR cells). (B) Iodide influx rates from VX-809-treated (3 μM, 48 h) F508del-CFTR cells, transfected with the indicated siRNAs. The 
average fluorescence decay was fitted to an exponential decay function to derive the maximal slope [d(F/F0)/dt, at t = 0] that is proportional to the initial influx of I− into the cells. 
(C) Iodide influx rates, calculated as in (B), for wt-CFTR CFBE cells, transfected as indicated. Data are means ± SEM of three independent assays. *p < 0.05; **p < 0.01.
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functional effect on both wt and VX-809-rescued F508del-CFTR 
observed here upon iNOS downregulation, our results suggest 
that, besides an improved resistance to microbial infection, any 
therapeutic approach that increased iNOS production in the 
airways might further benefit CF patients by stimulating residual 
CFTR function. This has, however, to be further investigated since, 
in a previous study, micromolar concentrations of NO were shown 
to inhibit forskolin-stimulated cAMP production by adenylyl 
cyclase and cAMP-dependent Cl− transport and fluid secretion 
mediated by CFTR (Spirli et al., 2003).
SMURF1 functions as an E3 ubiquitin ligase protein and has 
been shown previously to regulate endocytosis of other membrane 
proteins such as the bone morphogenetic protein type II receptor 
(BMPR), related to pulmonary arterial hypertension. Blockage of 
SMURF1 ubiquitin ligase activity increased cell surface expression 
of BMPR (Murakami and Etlinger, 2019). Here, we observed 
that depletion of SMURF1 produced a twofold stimulation of 
the iodide influx rate in CFTR wt cells but did not promote any 
significant rescue of F508del-CFTR to the PM. Moreover, while 
endogenous cAMP depletion by pretreatment with indomethacin 
delayed the response to Fsk in control wt-CFTR CFBE cells, this 
effect was much less pronounced upon SMURF1 knockdown. 
This is suggestive that the knockdown of these proteins can have 
an effect not only in CFTR’s PM abundance but also on its gating 
efficiency. Such an effect might nevertheless have therapeutic 
potential for class III to V CFTR mutations.
Similar effects were also observed upon knockdown of the 
GABA receptor-associated protein GABARAP, which belongs 
to the Atg8 family of ubiquitin-like proteins that are involved in 
the regulation of autophagy. GABARAP proteins associate with 
the membrane of the autophagosome through conjugation of 
phosphatidylethanolamine (Ichimura et al., 2000) and are primary 
drivers of autophagy working upstream of LC3 proteins and 
operate mainly at the late stages of autophagy driving the fusion 
of autophagosomes to lysosomes (Nguyen et al., 2016). Our results 
show that knockdown of GABARAP increased the temperature-
dependent stability and function at the PM of F508del-CFTR after 
correction with VX-809. Furthermore, depletion of GABARAP 
also increased wt-CFTR function and, similar to SMURF1 
knockdown, its response to Fsk stimulation after pretreatment 
with indomethacin. Since we observed no detectable impact of 
GABARAP downregulation on wt-CFTR traffic, it is possible that 
GABARAP may function by stabilizing the molecular machinery 
required to anchor and activate CFTR at the PM, thus increasing its 
FIGURE 4 | GABARAP downregulation increases rescued F508del-CFTR PM abundance. (A) Confocal images of Dox-induced, mCherry-Flag-wt-CFTR expressing 
CFBE cells. Images are of double-labeled non-permeabilized cells, where mCherry fluorescence is proportional to the total amount of CFTR and Alexa Fluor 488 
fluorescence is proportional to the amount of CFTR present at the cell surface. A 0.2-μm Z-stack of 1-Airy confocal images was acquired (top left inset) to select the 
best XY plane to analyze the CFTR protein at the cell surface. ImageJ software (NIH) was used to delimit each single cell as individual ROIs (regions of interest) to allow 
measurement of mCherry (red lined lattice) and Alexa488 (green lined lattice) fluorescence signal intensities. (B) Confocal images, obtained as in (A) of Dox-induced, 
VX-809-treated (3 μM, 48 h) mCherry-Flag-F508del-CFTR CFBE cells, transfected with either siLUC or siGABARAP and co-treated with 50 ng/ml HGF, when indicated. 
Cells were first pre-incubated for 24 h at 30°C to stabilize PM rescued F508del-CFTR and then moved to 37°C for 4 h to allow destabilization and internalization of 
the recued protein, unless otherwise prevented by the treatment conditions. White bars correspond to 10 μm. (C) Analysis of single-cell fluorescence signals in three 
independent experiments. Data presented refer to mean values ± SEM of three independent assays. CFTR at the surface was estimated by the ratio of Flag/mCherry 
signals in all conditions and expressed as percentage of surface F508del-CFTR at 30°C (siLUC, black bars) or surface wt-CFTR at 37°C (gray bars). *p < 0.05; **p < 0.01.
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gating efficiency. While the high levels of wt-CFTR at the surface 
may have led to an underestimation of fluorescence signals at the 
cell surface, the PM stabilizing effects observed with VX-809-
rescued F508del-CFTR seem to support a functional potentiation 
hypothesis. In this case, interference with GABARAP activity may 
also prove beneficial for class III to class V CFTR mutations.
The identification of novel regulators of CFTR levels at the PM 
has important biomedical implications. The pharmacological 
rescue of mutant CFTR folding or gating improves symptoms in 
CF patients (Zhang et al., 2016); however, a truly relevant clinical 
benefit appears to require the targeting of additional cellular 
processes: the trafficking of CFTR as well as its retention at the 
PM (Farinha and Matos, 2016). The proteins identified here 
suggest that the cellular processes of membrane traffic, protein 
stabilization at the PM, and NO signaling are suitable targets for 
novel therapeutic approaches in CF.
Besides providing new insights into CFTR biology and suggesting 
possible therapeutic targets in CF, the network biology approach 
delineated in this work provides a framework applicable to other 
human diseases related to the traffic and function of PM transport 
proteins.
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